Trial intelligence / Profile preview

Observational study of lidocaine levels in children after airway topicalisation during DLTB

2014-005207-25Phase 3Completed

Sponsor
Manchester University NHS Foundation Trust
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of lidocaine in None, sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Plasma peak concentration of lidocaine during DLTB. Started Dec 2015; status: completed.

02

Drugs

lidocaine

Beyond the preview

Go deeper on 2014-005207-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005207-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call